Literature DB >> 17081865

Anterior segment OCT and phakic intraocular lenses: a perspective.

Georges Baïkoff1.   

Abstract

Perfect tolerance is expected when one implants a phakic intraocular lens (pIOL) in the anterior segment. Not only should the material be compatible, but the pIOL must respect the anatomy of the anterior chamber. Based on 3 years of experience using an anterior segment optical coherence tomographer (Visante OCT, Carl Zeiss Meditec), I have defined numerous safety criteria for pIOLs. The internal dimensions of the anterior chamber must be considered along different meridians. I propose an objective measurement of the iris dome, the crystalline lens rise (CLR), which is the distance between the anterior pole of the crystalline lens and a line joining the 2 opposite iridocorneal angles. In a series with the Artisan IOL (Ophtec), pigment dispersion syndrome appeared in 70% of cases in which the CLR was greater than 600 microm. Angle-supported IOLs must be placed relative to the anterior chamber's largest diameter; in the same series of cases, the anterior chamber was oval with a large vertical axis in 74% of cases. The posterior face of an angle-supported IOL must have a 700 microm vault to respect the physiological modifications of the crystalline lens. It is difficult to know the posterior chamber's exact diameter as it varies with the horizontal or vertical axis. It also undergoes constant modifications due to accommodation and aging.

Entities:  

Mesh:

Year:  2006        PMID: 17081865     DOI: 10.1016/j.jcrs.2006.08.025

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  Long-term evaluation of the central vault after phakic Collamer® lens (ICL) implantation using OCT.

Authors:  Jose F Alfonso; L Fernández-Vega; C Lisa; P Fernandes; J González-Meijome; R Montés-Micó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-28       Impact factor: 3.117

2.  AcrySof phakic angle-supported intraocular lens for the correction of high to extremely high myopia: one-year follow-up results.

Authors:  Rui-Bo Yang; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

3.  Comparison of preoperative simulated and postoperative real safety distances using anterior segment OCT in patients with phakic IOL according to iris configuration.

Authors:  Maria A Henriquez; Maythe Camino-Quezada; Or Ben-Shaul; Luis Izquierdo
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

4.  Spectral domain optical coherence tomography for glaucoma (an AOS thesis).

Authors:  Joel S Schuman
Journal:  Trans Am Ophthalmol Soc       Date:  2008

Review 5.  Phakic Intraocular Lenses and their Special Indications.

Authors:  Roberto Pineda; Tulika Chauhan
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

6.  Severe pigment dispersion after iris-claw phakic intraocular lens implantation.

Authors:  Virgilio Galvis; Néstor I Carreño; Alejandro Tello; Andrea N Laiton
Journal:  Indian J Ophthalmol       Date:  2017-12       Impact factor: 1.848

7.  Assessment of anterior segment parameters under photopic and scotopic conditions in Indian eyes using anterior segment optical coherence tomography.

Authors:  Shaun Dacosta; Gitanjali Fernandes; Babu Rajendran; P Janakiraman
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

8.  Stability of cachet phakic intraocular lens position during 6-months follow-up.

Authors:  D Schiano Lomoriello; M Lombardo; L Gualdi; L Iacobelli; L Tranchina; P Ducoli; S Serrao
Journal:  Open Ophthalmol J       Date:  2013-03-22

9.  Endothelial distance after phakic iris-fixated intraocular lens implantation: a new safety reference.

Authors:  Tiago Bravo Ferreira; Joana Portelinha
Journal:  Clin Ophthalmol       Date:  2014-01-17

10.  In Vivo Positional Analysis of Implantable Collamer Lens Using Ultrasound Biomicroscopy.

Authors:  Ahmed Mohamed Kamal Elshafei; Mahmoud Mohamed Genaidy; Hossam Mohamed Moharram
Journal:  J Ophthalmol       Date:  2016-09-08       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.